Business Context and Reporting Period
This Form 8-K filing by Colgate-Palmolive Company (CL) reports a material event occurring on September 19, 2019, with the report filed on September 20, 2019. The filing details the completion of a previously announced acquisition.
Key Financial Metrics
The filing discloses specific transaction costs but does not provide updated consolidated revenue, profit, cash flow, margins, debt, or liquidity metrics for the company as a whole.
- Acquisition Target: Laboratoires Filorga Cosmétiques
- Purchase Price (EUR): Approximately €1,516 million
- Purchase Price (USD): Approximately $1,674 million
- Payment Method: Cash
- Price Composition: Includes interest on the previously disclosed equity purchase price
Material Changes
The primary material change is the successful closing of the acquisition of Laboratoires Filorga Cosmétiques, executed pursuant to a Share Purchase Agreement dated July 11, 2019. This transaction expands Colgate's presence in the prestige skincare market.
Guidance, Outlook, and Risks
The filing text does not provide updated financial guidance, management commentary on future outlook, specific risk factors, or contingencies related to this transaction beyond the completion of the purchase. No unusual items were disclosed in this specific report.
Investor Verification Checklist
- Verify the final exchange rate used to convert the €1,516 million purchase price to $1,674 million.
- Review the impact of the $1,674 million cash outflow on the company's current liquidity and debt covenants.
- Confirm the integration timeline and expected synergies for Laboratoires Filorga Cosmétiques in subsequent earnings releases.
- Check for any regulatory approvals or conditions precedent that were satisfied to close the deal on September 19, 2019.